Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Cardiovascular Endocrinology

Association Between Vascular Aging and Cardiovascular-Kidney-Metabolic Syndrome

Provisionally accepted
Shuyi  ZengShuyi ZengHenghua  CuiHenghua CuiWang  LiaoWang LiaoShiyu  QiuShiyu QiuZhengdong  WangZhengdong WangZijia  WuZijia WuMing  LiuMing LiuLei  ChenLei Chen*
  • Department of Cardiology, The First People’s Hospital of Yulin, the sixth affiliated hospital of Guangxi Medical University, Yulin, China

The final, formatted version of the article will be published soon.

Background: The concept of Cardiovascular-Kidney-Metabolic syndrome (CKM), an intricate interplay among metabolic risk factors, chronic kidney disease (CKD), and the cardiovascular system, was introduced by the American Heart Association (AHA). This indicates a markedly increased susceptibility to various organ dysfunctions and adverse cardiovascular events. In CKM management, reliable markers are critical. The purpose of this study was to investigate the relationship between ePWV and mortality and prognosis in patients with CKM. Methods: This study included 14,372 participants from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018. ePWV assessed vascular aging and arterial stiffness. The association between ePWV and CKM, as well as their risk of death, was analysed using weighted logistic regression and Cox proportional hazards models. Bootstrap sampling was used to analyse the mediating effect of the Triglyceride-Glucose Index (TyG) between ePWV and CKM. The Stage 4 ePWV threshold was further validated using an independent retrospective cohort of 3,157 patients from the cardiology department of a tertiary hospital in southern China. Results: The RCS analysis demonstrated a nonlinear positive association between estimated pulse wave velocity (ePWV) and cardiovascular–kidney–metabolic syndrome (CKM) (P < 0.01). Subgroup analysis indicated that this association was strongest among young adults aged 20–40 years (P < 0.01), whereas no significant association was observed in elderly individuals over 75 years old (P = 0.791). Kaplan– Meier curves showed that individuals with higher ePWV had significantly worse survival than those with lower ePWV. Further mediation analysis revealed that the triglyceride–glucose (TyG) index mediated 25.23% of the association between ePWV and CKM. In the external validation cohort, the ePWV threshold corresponding to CKM Stage 4 was 8.52, which was consistent in direction and statistical significance with the NHANES-derived model. Conclusion: Elevated ePWV is nonlinearly associated with increased CKM risk, particularly among young adults. This finding provides insights into managing arterial

Keywords: Cardiovascular–kidney–metabolic syndrome, Cardiorenal syndromes, metabolic syndrome, Vascular Stiffness, pulse wave velocity

Received: 25 Sep 2025; Accepted: 10 Nov 2025.

Copyright: © 2025 Zeng, Cui, Liao, Qiu, Wang, Wu, Liu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lei Chen, chenleixinnei@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.